India takes action against 90% of inspected high-risk pharmaceutical facilities, regulator saysAmid increasing global concerns over Indian pharmaceuticals, India's drug regulator is rigorously addressing high-risk manufacturing sites....
30 Jul, 2026, 05.10 PM IST
Cupid increases investment by $5 million in GII’s Healthcare-focused platformCupid Ltd has made an additional $5 million investment in GII’s healthcare-focused investment platform, funded through internal accruals. T...
30 Jul, 2026, 02.45 PM IST
FSSAI suspends licence of Dior Pharmaceuticals for violations at nutraceutical plantThe FSSAI has suspended Dior Pharmaceuticals' license due to serious violations. The nutraceutical factory operated with severely deficient...
30 Jul, 2026, 02.34 PM IST
Motilal Oswal raises mid and smallcap allocation to 50%, stays neutral on Indian equitiesMotilal Oswal Private Wealth favors Indian mid and small-cap stocks. They are increasing allocations to these segments by ten percentage po...
30 Jul, 2026, 05.40 AM IST
Edelweiss Alternatives raises over Rs 1,200 crore for second Discovery fund; backs Arboreal BioEdelweiss Alternatives Asset Advisors has secured over Rs 1,200 crore for its second Discovery Fund and made its first investment by leadin...
29 Jul, 2026, 04.22 PM IST
Centre readies healthcare compliance overhaul to boost hospitals in tier-2, tier-3 citiesIndia plans major healthcare regulatory changes soon. These reforms aim to simplify licensing and reduce compliance burdens. The govt will ...
28 Jul, 2026, 04.52 PM IST
Sakar Healthcare posts Rs 10-crore profit in Q1Sakar Healthcare announced a substantial net profit increase for the first quarter of 2026-27. The company's revenue from operations also s...
28 Jul, 2026, 01.42 PM IST
Tariff on generic drugs: Loud announcement, little consequence? 7 pharma stocks with upside potential of up to 31%The threat of a US tariff on Indian pharma is no longer a vague fear; or at least that is what President Trump wants us to believe. There i...
27 Jul, 2026, 12.52 PM IST
FSSAI suspends licence of Westend Agro Products for altering expiry dates, other violationsThe food regulator FSSAI suspended Westend Agro Products' license due to serious violations. Inspection revealed altered manufacturing and ...
26 Jul, 2026, 04.01 PM IST
US tariff proposal wake-up call for Indian pharma to diversify, innovate: ExpertsUS pharma tariffs: Experts have urged a shift towards global diversification and prioritising innovation for Indian pharma to lessen market...
26 Jul, 2026, 02.45 PM IST
FSSAI penalises Sopan Restaurant for sub-standard pantry car food on Chandigarh-Dibrugarh ExpressThe FSSAI has penalised Sopan Restaurant for selling sub-standard food. This action followed an analysis of milk samples from a train pantr...
25 Jul, 2026, 05.57 PM IST
Bain Capital acquires Vitabiotics: UK nutraceutical giant with India’s Meyer Organics valued at $850-900 millionPrivate equity firm Bain Capital has agreed to acquire UK-based nutraceutical company Vitabiotics, expanding its presence in the global wel...
25 Jul, 2026, 06.00 AM IST
Cabinet approves Rs 3,030 crore Bhavya Rasayan Scheme for three chemical parksWith a financial commitment of Rs 3,030 crore, the Union Cabinet has approved the Bhavya Rasayan Scheme. This forward-thinking initiative w...
24 Jul, 2026, 07.31 PM IST
FSSAI suspends license of Punjab-based Rehaan Healthcare for breach of norms at manufacturing unitThe FSSAI has suspended Rehaan Healthcare's license after finding serious rule violations. The company's manufacturing unit was found in an...
24 Jul, 2026, 06.18 PM IST
Bain Capital to accquire UK's leading vitamin company VitabioticsPrivate equity firm Bain Capital will acquire UK nutraceutical company Vitabiotics, including its India business Meyer Organics and African...
24 Jul, 2026, 01.41 PM IST
FSSAI suspends Rehaan Healthcare licence over serious food safety violationsFSSAI has suspended Rehaan Healthcare’s licence after inspections revealed serious violations at its health supplements and nutraceutical m...
24 Jul, 2026, 11.08 AM IST
LetterOne taps Rahul Mukim to spearhead $2 billion India pushLuxembourg-based LetterOne appointed Rahul Mukim to lead its India investments. The firm plans a significant $2 billion investment program ...
17 Jul, 2026, 04.57 PM IST